Global Checkpoint Inhibitors for Treating Cancer Market Study 2015-2025, by Segment (PD-1 inhibitors, PD-L1 inhibitors, CTLA-4 inhibitors), by Market (Melanoma treatment, Bladder cancer treatmentPD-L1 inhibitors, Others), by Company (Bristol-Myers Squibb(BMS), Merck, Roche)
SNAPSHOT
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
The global Checkpoint Inhibitors for Treating Cancer market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
The global Checkpoint Inhibitors for Treating Cancer market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
- PD-1 inhibitors
- PD-L1 inhibitors
- CTLA-4 inhibitors
- Melanoma treatment
- Bladder cancer treatment
- Others
- Bristol-Myers Squibb(BMS)
- Merck
- Roche
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
1 INDUSTRY OVERVIEW
1.1 Checkpoint Inhibitors for Treating Cancer Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET BY TYPE
2.1 By Type
2.1.1 PD-1 inhibitors
2.1.2 PD-L1 inhibitors
2.1.3 CTLA-4 inhibitors
2.2 Market Size by Type
2.3 Market Forecast by Type
3 GLOBAL MARKET DEMAND
3.1 Segment Overview
3.1.1 Melanoma treatment
3.1.2 Bladder cancer treatment
3.1.3 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 MAJOR REGION MARKET
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 MAJOR COMPANIES LIST
5.1 Bristol-Myers Squibb(BMS) (Company Profile, Sales Data etc.)
5.2 Merck (Company Profile, Sales Data etc.)
5.3 Roche (Company Profile, Sales Data etc.)
6 CONCLUSION
1.1 Checkpoint Inhibitors for Treating Cancer Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET BY TYPE
2.1 By Type
2.1.1 PD-1 inhibitors
2.1.2 PD-L1 inhibitors
2.1.3 CTLA-4 inhibitors
2.2 Market Size by Type
2.3 Market Forecast by Type
3 GLOBAL MARKET DEMAND
3.1 Segment Overview
3.1.1 Melanoma treatment
3.1.2 Bladder cancer treatment
3.1.3 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 MAJOR REGION MARKET
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 MAJOR COMPANIES LIST
5.1 Bristol-Myers Squibb(BMS) (Company Profile, Sales Data etc.)
5.2 Merck (Company Profile, Sales Data etc.)
5.3 Roche (Company Profile, Sales Data etc.)
6 CONCLUSION
LIST OF TABLES
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2018, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2018, by Type, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2025, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2025, by Type, in Volume
Table Bristol-Myers Squibb(BMS) Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2018, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2015-2018, by Type, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2025, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2025, by Type, in Volume
Table Bristol-Myers Squibb(BMS) Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
LIST OF FIGURES
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2015-2018, by Type, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2015-2018, by Type, in Volume
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2015-2018, by Type, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2015-2018, by Type, in Volume
